Rybelsus
Semaglutide
Oral semaglutide for patients who prefer a tablet
Oral prescription medication for adults with type 2 diabetes in a clinician-supervised personalized treatment plan.
Rybelsus® may be prescribed off-label for weight management when clinically appropriate.

About Rybelsus
Rybelsus® is the oral form of semaglutide, FDA-approved for type 2 diabetes. For patients who prefer daily tablets over injections, it may be considered when clinically appropriate — including off-label weight-management evaluation by your provider.
Key benefits
- Needle-free daily dosing option for eligible patients
- GLP-1 receptor support for glucose and appetite regulation
- May suit patients uncomfortable with injections
- Physician-guided titration and monitoring
Who may qualify
- Medical suitability determined through full clinician evaluation
- Specific fasting/timing requirements for oral absorption
- Off-label weight use based on independent clinical judgment
How treatment works
Clinician consult
Discuss oral vs. injectable options based on your preferences and health profile.
Dosing instructions
Your provider explains daily timing, fasting requirements, and titration.
Progress monitoring
Follow-up visits assess tolerance, efficacy, and plan adjustments.
Good to know
- Must be taken on an empty stomach with water; wait before eating.
- Not interchangeable with injectable semaglutide dosing.
- Side effects may include nausea and digestive discomfort.
GLP-1 medications are available by prescription only after a licensed provider determines eligibility. This information is educational and not medical advice.
Common questions
Efficacy depends on individual response, adherence, and clinical context. Your provider helps determine the most appropriate formulation for you.
Medication changes must be directed by your licensed clinician after reviewing your progress and medical history.